Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), sold 69,850 shares at $4.30 ($300K) on 2014-01-13, disclosed to the SEC on 2014-01-14.
Scheduled sale ($300k) by CEO & Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.25 | 2,000 | $9K | 2.8% |
| 2 | $4.30 | 67,850 | $292K | 97.2% |
| Total | $4.30 avg | 69,850 | $300K | 100% |
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |